Language

Regional Liquid Biopsy Market Development, Dynamics and SWOT Analysis 2024-2030

Length- 106 Pages | Published Date - 2024-02-11 | Report Id- 7889
Single Licence $4380.00 | Enterprise License $7500.00 | Multiple Licensee $7500.00
Description Table of Contents Table of Figures
The global Liquid Biopsy market size in 2023 is 10300.0 million US dollars, and it is expected to be 24382.3 million US dollars by 2030, with a compound annual growth rate of 13.1% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Liquid Biopsy market include ANGLE plc, Oncimmune, Guardant Health, Inc., Myriad Genetics, Inc., and Biocept, Inc.. The share of the top 3 players in the Liquid Biopsy market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Liquid Biopsy market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Multi-gene-parallel Analysis (NGS) accounted for XX% of Liquid Biopsy market in 2023. Single Gene Analysis (PCR Microarrays) share of XX%.
Therapy Selection accounted for XX% of the Liquid Biopsy market in 2023. Treatment Monitoring accounts for XX%.

This Liquid Biopsy market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

Liquid Biopsy market country level analysis
The countries covered in the Liquid Biopsy market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and Liquid Biopsy Market Share Analysis
Liquid Biopsy market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Liquid Biopsy market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Liquid Biopsy industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Liquid Biopsy market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global Liquid Biopsy market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Liquid Biopsy market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the Liquid Biopsy business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa

Player list
ANGLE plc
Oncimmune
Guardant Health, Inc.
Myriad Genetics, Inc.
Biocept, Inc.
Lucence Health Inc.
Freenome Holdings, Inc.
F. Hoffmann-La Roche Ltd.
QIAGEN
Illumina, Inc.

Types list
Multi-gene-parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)

Application list
Therapy Selection
Treatment Monitoring
Early Cancer Screening

Contact US Anytime

Contact US Anytime

Find More

Regional Liquid Biopsy Market Development, Dynamics and SWOT Analysis 2024-2030

Get a FREE sample

Have Requests? Need Customization? Our Research Team Will Help to Maximize Your "Interest Scope and Content Customization" into Our Analysis Report.

Custom Research
Dongguan Jianpeng Intelligent Technology Co., Ltd
top

Phone Number +86 195 30455980

Research Consulting reports@arstaresearch.com

Business Cooperation sales@arstaresearch.com

Copyright © 2020-2025 Arsta Research All Rights Reserved
Technical support : Cssl
Choose a different language
╳
English Español‎ Português Français Deutsch Русский Suomen Kieli Myanmar Tiếng Việt にほんご 한국어 Italiana हिन्दी Melayu ภาษาไทย اللغة العربية 中文(简体) 中文(繁体)

Sample Request

Message